Pittenger & Anderson Inc’s Editas Medicine EDIT Stock Holding History

Pittenger & Anderson Inc’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-75	Closed	-$5K	–	399
2020 Q4	$5K	Hold	75	–	–	﹤0.01%	330
2020 Q3	$2K	Buy	75 +23	+44%	+$749	﹤0.01%	345
2020 Q2	$2K	Hold	52	–	–	﹤0.01%	342
2020 Q1	$1K	Hold	52	–	–	﹤0.01%	340
2019 Q4	$2K	Hold	52	–	–	﹤0.01%	348
2019 Q3	$1K	Buy	52 +12	+30%	+$297	﹤0.01%	354
2019 Q2	$1K	Hold	40	–	–	﹤0.01%	359
2019 Q1	$1K	Hold	40	–	–	﹤0.01%	370
2018 Q4	$1K	Hold	40	–	–	﹤0.01%	354
2018 Q3	$1K	Hold	40	–	–	﹤0.01%	366
2018 Q2	$1K	Hold	40	–	–	﹤0.01%	374
2018 Q1	$1K	Hold	40	–	–	﹤0.01%	369
2017 Q4	$1K	Hold	40	–	–	﹤0.01%	388
2017 Q3	$1K	Buy	+40	New	+$761	﹤0.01%	372

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pittenger & Anderson Inc's EDIT Position: Q1 2021 in Review

Pittenger & Anderson Inc sold out of Editas Medicine (EDIT) in Q1 2021, closing a stake of 75 shares — an estimated $5K sold.

Pittenger & Anderson Inc first reported a position in EDIT in Q3 2017 and held it in 14 quarters. The position peaked at $5K in Q4 2020. 312 funds tracked by Wall St. Rank hold EDIT as of Q1 2021.

Pittenger & Anderson Inc reported no remaining Editas Medicine position as of Q1 2021 after selling out during the quarter.
Pittenger & Anderson Inc sold 75 Editas Medicine shares in Q1 2021, an estimated $5K.
Pittenger & Anderson Inc first reported a position in Editas Medicine in Q3 2017 and held it in 14 quarters.
Pittenger & Anderson Inc's Editas Medicine position peaked at $5K in Q4 2020.
312 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2021.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2021, filed 12 May 2021.